Palvella Therapeutics PVLA Return on equity

Return on equity at other companies

Relay Therapeutics, Inc.RLAY

-36.8%-6.3pp

Viridian Therapeutics, Inc.VRDN

-65.7%-0.1pp

ANI PharmaceuticalsANIP

21%+19.1pp

Arcutis Biotherapeutics, Inc.ARQT

-28.2%-13.0pp

Zevra Therapeutics, Inc.ZVRA

34.8%+31.3pp

Eton Pharmaceuticals, Inc.ETON

-34.2%+0.9pp

FAQ

What is Palvella Therapeutics's return on equity?

Palvella Therapeutics (PVLA) reported return on equity of -34.2% in Q1 2026.

What is the long-term trend for Palvella Therapeutics's return on equity?

Over 2 years (2020 to 2025), Palvella Therapeutics's return on equity has grown at a 0.9% compound annual growth rate (CAGR), from -90.4% to -92.1%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.